GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,076,000 | -9.7% | 47,693 | -9.6% | 0.04% | +13.5% |
| Q1 2022 | $2,298,000 | -14.3% | 52,747 | -13.2% | 0.04% | -9.8% |
| Q4 2021 | $2,680,000 | -30.3% | 60,779 | -39.6% | 0.04% | -30.5% |
| Q3 2021 | $3,846,000 | -13.9% | 100,652 | -10.3% | 0.06% | -11.9% |
| Q2 2021 | $4,467,000 | +8.6% | 112,188 | -2.7% | 0.07% | -1.5% |
| Q1 2021 | $4,113,000 | +5.3% | 115,245 | +8.6% | 0.07% | -2.9% |
| Q4 2020 | $3,905,000 | -34.2% | 106,127 | -32.7% | 0.07% | -40.2% |
| Q3 2020 | $5,935,000 | -17.0% | 157,671 | -10.1% | 0.12% | -24.0% |
| Q2 2020 | $7,150,000 | -0.7% | 175,293 | -7.7% | 0.15% | -19.8% |
| Q1 2020 | $7,198,000 | -45.6% | 189,960 | -32.5% | 0.19% | -30.7% |
| Q4 2019 | $13,233,000 | +9.2% | 281,619 | -0.8% | 0.28% | +3.7% |
| Q3 2019 | $12,115,000 | +5.7% | 283,845 | -0.9% | 0.27% | +2.7% |
| Q2 2019 | $11,463,000 | -3.1% | 286,426 | +1.1% | 0.26% | -7.5% |
| Q1 2019 | $11,834,000 | +16.9% | 283,184 | +6.9% | 0.28% | -2.1% |
| Q4 2018 | $10,126,000 | -6.3% | 264,998 | -1.5% | 0.29% | +6.7% |
| Q3 2018 | $10,808,000 | -6.1% | 269,048 | -5.8% | 0.27% | -22.7% |
| Q2 2018 | $11,516,000 | -11.0% | 285,698 | -13.7% | 0.35% | -28.0% |
| Q1 2018 | $12,939,000 | +70.8% | 331,174 | +55.0% | 0.48% | +70.7% |
| Q4 2017 | $7,577,000 | -50.8% | 213,614 | -43.6% | 0.28% | -49.1% |
| Q3 2017 | $15,390,000 | +3.6% | 379,071 | +10.0% | 0.56% | +9.0% |
| Q2 2017 | $14,856,000 | +10.9% | 344,530 | +8.4% | 0.51% | +4.7% |
| Q1 2017 | $13,399,000 | +18.4% | 317,824 | +8.2% | 0.49% | +5.6% |
| Q4 2016 | $11,315,000 | -22.2% | 293,824 | -12.9% | 0.46% | -27.6% |
| Q3 2016 | $14,547,000 | -7.2% | 337,276 | -6.8% | 0.64% | -8.9% |
| Q2 2016 | $15,681,000 | +16.2% | 361,820 | +8.7% | 0.70% | +5.9% |
| Q1 2016 | $13,493,000 | +9.9% | 332,751 | +9.4% | 0.66% | +7.1% |
| Q4 2015 | $12,274,000 | +13.8% | 304,194 | +8.5% | 0.62% | +9.8% |
| Q3 2015 | $10,782,000 | -5.1% | 280,408 | +2.8% | 0.56% | +8.7% |
| Q2 2015 | $11,364,000 | -4.0% | 272,845 | +6.4% | 0.52% | -4.3% |
| Q1 2015 | $11,833,000 | +14.3% | 256,398 | +5.8% | 0.54% | +10.0% |
| Q4 2014 | $10,355,000 | +6.8% | 242,290 | +14.8% | 0.49% | +2.1% |
| Q3 2014 | $9,700,000 | +52.0% | 211,000 | +76.8% | 0.48% | +49.5% |
| Q2 2014 | $6,383,000 | +22.2% | 119,351 | +22.1% | 0.32% | +12.6% |
| Q1 2014 | $5,223,000 | +9.8% | 97,746 | +9.7% | 0.28% | +20.8% |
| Q4 2013 | $4,757,000 | +7.1% | 89,097 | +0.7% | 0.24% | -1.3% |
| Q3 2013 | $4,441,000 | -12.2% | 88,516 | -12.5% | 0.24% | -15.2% |
| Q2 2013 | $5,058,000 | – | 101,218 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |